Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology ...
We are in the process of updating our Market Data experience and we want to hear from you. Please send us your feedback via our Customer Center ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results